Literature DB >> 9732184

Imaging techniques in the evaluation of adenocarcinoma of the pancreas.

R E Brand1, A Matamoros.   

Abstract

Adenocarcinoma of the pancreas is a highly malignant neoplasm that presents late and carries a dismal prognosis. Despite technical advances, the various imaging modalities used to evaluate and stage a pancreatic adenocarcinoma have not had a significant impact on survival rates. This article describes the various imaging modalities used to image and stage an adenocarcinoma of the pancreas and reviews their relative accuracy and limitations in diagnosing and staging this carcinoma. We conclude that for appropriate staging of adenocarcinoma of the pancreas, the combination of a computed axial tomography scan and an endoscopic ultrasound represents an efficient and cost-effective approach.

Entities:  

Mesh:

Year:  1998        PMID: 9732184     DOI: 10.1159/000016872

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  7 in total

1.  The specificity of amylin for the diagnosis of pancreatic adenocarcinoma.

Authors:  Randall E Brand; Xian-Zhong Ding; Christine M Young; Thomas E Adrian
Journal:  Int J Gastrointest Cancer       Date:  2002

Review 2.  Pancreatic cancer: can we screen? How should we stage?

Authors:  A A Parikh; A M Lowy
Journal:  Curr Gastroenterol Rep       Date:  1999-04

3.  Serum biomarker panels for the detection of pancreatic cancer.

Authors:  Randall E Brand; Brian M Nolen; Herbert J Zeh; Peter J Allen; Mohamad A Eloubeidi; Michael Goldberg; Eric Elton; Juan P Arnoletti; John D Christein; Selwyn M Vickers; Christopher J Langmead; Douglas P Landsittel; David C Whitcomb; William E Grizzle; Anna E Lokshin
Journal:  Clin Cancer Res       Date:  2011-02-15       Impact factor: 12.531

4.  Heterodimeric RGD-NGR PET Tracer for the Early Detection of Pancreatic Cancer.

Authors:  Lingyi Sun; Yongkang Gai; Zhonghan Li; Huiqiang Li; Jianchun Li; John Muschler; Rui Kang; Daolin Tang; Dexing Zeng
Journal:  Mol Imaging Biol       Date:  2022-02-28       Impact factor: 3.484

5.  Identification of Serum Biomarker Panels for the Early Detection of Pancreatic Cancer.

Authors:  Jin Song; Lori J Sokoll; Jered J Pasay; Abigail L Rubin; Hanying Li; Dylan M Bach; Daniel W Chan; Zhen Zhang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-10-17       Impact factor: 4.254

6.  Plasma metabolite biomarkers for the detection of pancreatic cancer.

Authors:  Guoxiang Xie; Lingeng Lu; Yunping Qiu; Quanxing Ni; Wei Zhang; Yu-Tang Gao; Harvey A Risch; Herbert Yu; Wei Jia
Journal:  J Proteome Res       Date:  2014-12-08       Impact factor: 4.466

7.  Validation of Serum Biomarkers That Complement CA19-9 in Detecting Early Pancreatic Cancer Using Electrochemiluminescent-Based Multiplex Immunoassays.

Authors:  Jin Song; Lori J Sokoll; Daniel W Chan; Zhen Zhang
Journal:  Biomedicines       Date:  2021-12-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.